Juvenile Idiopathic Arthritis (JIA) Recruiting Phase 1 Trials for Upadacitinib (DB15091)

Also known as: Arthritis, Juvenile Idiopathic / Juvenile Idiopathic Arthritis / Arthritis, Juvenile / Juvenile Arthritis / Juvenile seropositive arthritis

IndicationStatusPhase
DBCOND0056190 (Juvenile Idiopathic Arthritis (JIA))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03725007A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic ArthritisTreatment